PRESENTATION
Osmopharm is a Swiss pharmaceutical Company. Created in 1994, it is specialised in modified release systems for oral drugs, based on the application of some of the more advanced galenic technologies.
Osmopharm's major activity is the production under contract manufacturing by following the more strict GMP rules assured by Swissmedic and by prestigeous pharmaceutical companies inspection.
Its technical management, with about 40 years of experience, can study and develop new products offering to the costumers a global support for new registrations and/or for actualizing the existing ones by according to regulatory requirements.
Osmopharm staff is composed by about 100 persons that, in order to meet the customers expectations, is under a continuous challenge for studying new technologies and formulations and to maintain the highest Quality Levels.
MARKET & EVOLUTION
Osmopharm became, during the years, one of the worldwide leaders contract manufacturers in its field.
Today Osmopharm's pharmaceutical customers are over 100, most of them very prestigious.
The sales are worldwide distributed in more than 30 countries; the main market is Europe followed by north Africa, Asia, south and central America
Being Europe its main market, Osmopharm SA is committed to respect Swiss and European community rules.
Osmopharm's market goal is to enlarge its presence in the already existing markets and to enter in new ones.
In the shortest time, Osmopharm intends to register new dossiers by investing into new bioequivalences studies.
